Ayta, Bb Girl .
HRN: 27-66-39 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/21/2025
AMPICILLIN 250MG (VIAL)
08/21/2025
08/28/2025
IV
154mg
Q12
Sepsis Neonatorum
Checking Initial Appropriateness
08/21/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/21/2025
08/28/2025
IV
46mg
OD
Sepsis Neonatorum
Checking Initial Appropriateness